ReviewCancer treatment reviews2023

Inhibiting the inhibitors: Development of the IAP inhibitor xevinapant for the treatment of locally advanced squamous cell carcinoma of the head and neck.

Robert L Ferris et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.